Condition
Familial Hypertriglyceridemia
Total Trials
2
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Chenodeoxycholic Acid
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Early Phase 1 (1)
Trial Status
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Chenodeoxycholic Acid1
- Heredity For Pancreatitis1
- Heredity For Type 2 Diabetes1
- Heredity For Cardiovascular Disease1
- Heredity For Hypertriglyceridemia1
Active Sponsors
- University Hospital, Basel, Switzerland1
- Region Stockholm1
Top Investigators
Cantonal Hospital of St. Gallen
Related Conditions
- Metabolic Syndrome1
- Familial Combined Hyperlipidemia1